Renaissance Technologies
INBX icon

Renaissance Technologies’s Inhibrx INBX Stock Holding History

Renaissance Technologies’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89M Buy
62,201
+12,018
+24% +$1.2M 0.01% 1366
2026
Q1 		$3.37M Sell
50,183
-2,417
-5% -$179K 0.01% 1596
2025
Q4 		$4.16M Buy
52,600
+44,200
+526% +$3.01M 0.01% 1407
2025
Q3 		$283K Buy
+8,400
New +$207K ﹤0.01% 3022
2024
Q4 		– Sell
-25,100
Closed -$393K – 3726
2024
Q3 		$393K Buy
+25,100
New +$353K ﹤0.01% 2882

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies's INBX Position: Q2 2026 in Review

Renaissance Technologies increased its Inhibrx (INBX) stake by 24% in Q2 2026, buying an estimated $1.2M and bringing the position to 62,201 shares worth $5.89M. The position accounts for 0.01% of the portfolio, ranked #1366.

Renaissance Technologies first reported a position in INBX in Q3 2024 and has held it in 5 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Renaissance Technologies held 62,201 shares of Inhibrx worth $5.89M as of Q2 2026.
  • Renaissance Technologies bought 12,018 Inhibrx shares in Q2 2026, an estimated $1.2M.
  • Inhibrx made up 0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1366 holding.
  • Renaissance Technologies first reported a position in Inhibrx in Q3 2024 and has held it in 5 quarters since.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.